In a sub-analysis in people with albuminuria at baseline, lixisenatide reduced UACR by 21% (in people with microalbuminuria) 39% (in people with macroalbuminuria)
Jun 2014;52(6):e123-125
Frost, PhD, is Southern California leader of Stop The BOP
If you want a deeper understanding of how GLP-1 medications affect metabolism, appetite, nutrition, and long-term weight management, explore the full GLP-1 Optimization Guide on Fueled Framework
151 , 678687 (2007) Conner, A
Co-founder & Lead Biochemist - Vitall|Profile Reviewed on 20/10/2025 Next review due 20/10/2026 Review focus: Blood biomarkers, laboratory testing methodology, and biochemical interpretation